ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 672073 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 672073; 2) Community: the network communities that were significantly associated with the response to NSC 672073; 3) Molecule: the relationships between components within communities and NSC 672073; 4) MDR: the compounds that were significantly associated with the NSC 672073.

NSC Compound Enrichment Correlation
NSC 681684 2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol 3.2500610178177e-005 0.37248269
NSC 667047 2-propenyl estradiol 3.84182410752308e-006 0.35040199
NSC 753222 3-Hydroxy-5,6-dihydro-6-imino-8,9-dimethylisoindolo-[2,1-a]quinoxaline 4.18332145614864e-005 0.37776043
NSC 717147 Null 4.88335076207314e-005 -0.20980552
NSC 282159 EN 589 6.70485325419773e-005 0.1667855
NSC 670337 Null 6.70485325419773e-005 0.3355804
NSC 669728 Null 8.31228411274747e-005 0.24493462
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 8.31228411274758e-005 0.11528418
NSC 86371 Quinolinium, 2-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1,6-dimethyl- iodide 9.15580043872282e-005 0.24558195
NSC 626167 Aplidazole C . TFA 9.15580043872288e-005 0.26100519
Total:88  Current:88    [First] [Prev] [Next] [Last]